These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Review article: the unmet needs in delayed-release proton-pump inhibitor therapy in 2005. Hunt RH. Aliment Pharmacol Ther; 2005 Dec 15; 22 Suppl 3():10-9. PubMed ID: 16303032 [Abstract] [Full Text] [Related]
6. Treatment with proton pump inhibitors in acute non-variceal upper gastrointestinal bleeding: a meta-analysis. Khuroo MS, Khuroo MS, Farahat KL, Kagevi IE. J Gastroenterol Hepatol; 2005 Jan 15; 20(1):11-25. PubMed ID: 15610441 [Abstract] [Full Text] [Related]
7. [Chemotherapy and NSAIDs in neoplastic disease. Role of anti-secretory preventive therapy]. Annibale B, Panzuto F. Recenti Prog Med; 2003 Nov 15; 94(11):473-7. PubMed ID: 14679914 [Abstract] [Full Text] [Related]
8. Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux. Miner PB. Aliment Pharmacol Ther; 2006 Mar 15; 23 Suppl 1():25-32. PubMed ID: 16483267 [Abstract] [Full Text] [Related]
9. Prevention of anti-inflammatory drug-induced gastrointestinal damage: benefits and risks of therapeutic strategies. Lanas A, Hunt R. Ann Med; 2006 Mar 15; 38(6):415-28. PubMed ID: 17008305 [Abstract] [Full Text] [Related]
10. Review article: the pharmacodynamics and pharmacokinetics of proton pump inhibitors--overview and clinical implications. Robinson M. Aliment Pharmacol Ther; 2004 Nov 15; 20 Suppl 6():1-10. PubMed ID: 15496213 [Abstract] [Full Text] [Related]
11. Proton pump inhibitor formulary considerations in the acutely ill. Part 1: Pharmacology, pharmacodynamics, and available formulations. Devlin JW, Welage LS, Olsen KM. Ann Pharmacother; 2005 Oct 15; 39(10):1667-77. PubMed ID: 16118266 [Abstract] [Full Text] [Related]
12. Oral complications of cancer therapy. Redding SW. Tex Med; 2003 May 15; 99(5):54-7. PubMed ID: 12772642 [Abstract] [Full Text] [Related]
14. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients. Hitchcock YJ, Tward JD, Szabo A, Bentz BG, Shrieve DC. Int J Radiat Oncol Biol Phys; 2009 Mar 01; 73(3):779-88. PubMed ID: 18707819 [Abstract] [Full Text] [Related]
16. Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence. Cooper BT, Chapman W, Neumann CS, Gearty JC. Aliment Pharmacol Ther; 2006 Mar 15; 23(6):727-33. PubMed ID: 16556174 [Abstract] [Full Text] [Related]